STOCK TITAN

Larson to sell 58,502 shares under Form 144 (SLDE NASDAQ)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Matthew Larson proposes to sell 58,502 shares of Common Stock under a Form 144 notification related to the exercise of stock options. The filing lists multiple prior 10b5-1 sales by Larson in March–April 2026, with individual trades such as 44,752 shares sold on 04/29/2026 for $895,939.52.

The transaction is processed through Morgan Stanley Smith Barney LLC. The Form 144 shows sale dates and per-trade proceeds for recent 10b5-1 transactions; timing and additional conditions are as stated in the filing.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 reporting of option-related sales under a 10b5-1 plan.

The filing documents a proposed sale of 58,502 shares from an exercise of stock options and lists multiple executed 10b5-1 sales in March–April 2026. The broker listed is Morgan Stanley Smith Barney LLC.

Observers should note that the presence of a 10b5-1 sales schedule typically indicates pre-arranged dispositions; the filing itself lists per-trade shares and proceeds but does not state broader financial impact.

Proposed shares to sell 58,502 shares listed under Securities To Be Sold, <date>05/04/2026</date>
Recent 10b5-1 sale 44,752 shares sold on <date>04/29/2026</date> for <money>$895,939.52</money>
Recent 10b5-1 sale 11,250 shares sold on <date>04/27/2026</date> for <money>$211,213.13</money>
Recent 10b5-1 sale 11,250 shares sold on <date>04/20/2026</date> for <money>$218,180.25</money>
Recent 10b5-1 sale 22,500 shares sold on <date>02/25/2026</date> for <money>$427,511.25</money>
10b5-1 regulatory
"10b5-1 Sales for MATTHEW LARSON 04/29/2026 44,752 shares"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Exercise of Stock Options financial
"Securities To Be Sold | 05/04/2026 | Exercise of Stock Options"
Form 144 regulatory
"144: Filer Information 144: Issuer Information 144: Securities Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Matthew Larson's Form 144 for SLDE report?

It reports a proposed sale of 58,502 shares of Common Stock. The filing ties the sale to an exercise of stock options and lists executed 10b5-1 sales in March–April 2026 with per-trade proceeds shown.

Which broker is handling the reported sale in Form 144 for SLDE?

Morgan Stanley Smith Barney LLC is listed as the broker. The filing shows the broker's address and indicates the transactions are processed through that firm for the reported option exercise and 10b5-1 sales.

Were there recent 10b5-1 sales by Matthew Larson before this Form 144?

Yes. Multiple 10b5-1 sales are listed in March–April 2026. Examples include 44,752 shares on 04/29/2026 for $895,939.52 and other dated trades with stated proceeds.

Does the Form 144 state how proceeds will be used?

The filing does not state a use-of-proceeds purpose in the provided excerpt. It lists share counts, sale dates, and dollar proceeds for individual trades, but no allocation of proceeds is shown in the excerpt.